Abiopharma

Surrozen to Present at Upcoming Healthcare Investor Conference

Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy

Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update

Cross Country Healthcare Announces Second Quarter 2025 Financial Results

Enhabit Home Health & Hospice - Enhabit Home Health & Hospice Announces CEO Transition Plan

Brookdale Senior Living Inc. - Brookdale Announces Second Quarter 2025 Results and Increases Annual Guidance

Keros to Exclusively Prioritize the Clinical Advancement of KER-065

Certara Reports Second Quarter 2025 FinancialResults

Enhabit Home Health & Hospice - Enhabit Reports Second Quarter 2025 Financial Results

Trinseo - Trinseo Reports Second Quarter 2025 Financial Results and Provides 2025 Outlook

SOBR Safe Expands Global Intellectual Patent Portfolio with Issuance of European Patent

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth

Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results